MedTrace Logo

Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral Revascularization

NCT01799811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-08-19

No results posted yet for this study

Summary

The objective Study is to evaluate the short- and long-term clinical outcomes of patients receiving the CryoVein cryopreserved saphenous vein allograft (CVA) as their primary open bypass conduit to assess if there is a quantifiable correlation to time of placement as a primary bypass graft and improved long-term clinical outcomes of patients with critical limb ischemia (CLI).

Conditions

  • Critical Limb Ischemia
  • Peripheral Arterial Disease

Sponsors & Collaborators

  • CryoLife, Inc.

    lead INDUSTRY

Principal Investigators

  • Scott B Capps, MS · CryoLife, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799811 on ClinicalTrials.gov